An expert panel convened to explore the multifactorial condition, MGD, and assess the science that may yield symptom relief.
Is Artificial Intelligence (AI) the solution to saving ophthalmologists’ time?
Higher Molar Dose and Its Translation into Clinical Practice
Data from self-tonometry supports glaucoma treatment decisions
Updates From Angiogenesis-2022
Espansione Group: Pioneering Light-Based Solutions in Ophthalmology
Onboarding a new trifocal hydrophobic C-loop IOL My early experiences with AT ELANA® 841P from ZEISS